3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
2
Neoplasms
1
Breast Neoplasms, Male
1
Interventions
Cyclophosphamide
5
Gemcitabine
4
Albumin-Bound Paclitaxel
4
Trastuzumab
3
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
3
pazopanib
2
Taxes
2
Sorafenib
2
Radiotherapy
2
Radiation
2
Paclitaxel
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Lapatinib
2
Doxorubicin
2
Docetaxel
2
Capecitabine
2
romidepsin
1
rV-Tricom
1
peginterferon alfa-2a
1
pegfilgrastim
1
oblimersen
1
methyl N-acetylsibirosaminide
1
ixabepilone
1
fludarabine phosphate
1
fludarabine
1
exemestane
1
cediranib
1
alvocidib
1
Zoledronic Acid
1
Whole-Body Irradiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Breast Neoplasms, Male
×
Testosterone
×
Clear all
NCT05156606
2024-08-09
T&T
University Medical Center Groningen
Phase NA
Terminated
5 enrolled